Calcitonin gene-related peptide (CGRP), regarded by several authors to be involved in maintenance of the acetylcholine receptor, is present in the motor axons of various striated rat muscles. It is present, however, only in motor endplates of several selected striated muscles, where it is located in presynaptic axon terminals of neuromuscular junctions. No immunoreactivity could be seen within synaptic vesicles themselves. In the non-human primate Macaca fasciculata, neuromuscular junctions, including those in the diaphragm, display an intense CGRP reaction. The structure of the simian motor endplates is more elaborate than that of the rat. Amphibian motor nerve endings, both in tetanic and tonic muscles, display CGRP immunoreactivity. In tetanic m d e s the CGRP reaction outlines "terminaisons en placque" (true motor end plates) and weakly reacting "terminaisons en grappe" (grape-like endings) in tonic muscles. On supramaximal stimulation of the motor nerve, CGRP is depleted from the affected neuromuscular junctions. Wallerian degeneration of the motor axon results in complete disappearance of CGW. In most rat muscles in which motor endplates do not normally exhibit CGRP
Introduction
Calcitonin gene-related peptide (CGRP), consisting of 37 amino acids, is known to be derived from the splicing of the gene that regulates calcitonin expression (31) . A large body of experimental evidence proves that CGRP is involved in the function of primary nociceptive neurons (21). On the other hand, CGRP present in ter-Supported by the OTKA Hungarian National Research Fund (Grants 952 and 2707) and by fellowships from Fogarty International Center (BC) and from the Section of Neurobiology of Yale University Medical School (EKC).
Present address: Section of Neurobiology, Yale Medical School, New Haven, Correspondence to: Prof. B. Gillik, Dept. of Anatomy, Albert Szent-Gyorgyi Med. Univ., PO Box 512, Hungary. immunoreactivity, e.g., the diaphragm and buccinator muscles, the pre-terminal motor axons are CGRP-positive. After immobilization of such muscles by local bupivacaine injection to rats under brief chloral hydrate anesthesia, CGRP immunoreactivity of the neuromuscular junctions can be elicited because blockade of neuromuscular transmission results in accumulation of CGRP in the endplates. Even more striking is the appearance of CGRP immunoractivity in normally non-reactive motor endplates during axon regeneration after an experimentally induced Wallerian degeneration of the motor axons. We condude that CGRP is a regular, genotypically determined component of neuromuscular junctions, present either in a manifest or in a latent form. The latter can be elicited by various experimental approaches. The presence of CGRP in the motor endplate supports the theory that this peptide is instrumental in maintenance of the acetylcholine receptor. ( J Hstochem Cytochem 41: KEY WORDS: CGRP; Motor endplate (mammalian, primate, amphibian); Acetylcholine receptor; Immobilization; Bupivacaine inactivation; Regeneration; Degeneration. -1555, 1993) minals of mons deriving from the parabrachial nucleus and terminating in several forebrain nuclei, such as the central nucleus of the amygdala, the septofimbrial nucleus, and the bed nucleus of the stria terminalis, has been shown to play an important role in various behavioral reactions (15). Finally, another set of investigations suggest that CGRP regulates synthesis of the acetylcholine receptor (AChR) in motor endplates (3,4,12), which has been substantiated by the presence of CGRP in motor axon terminals of the neuromuscular junction (36). However, recent studies from Dahlstrom's laboratory (1) have raised serious doubts with regard to the presence of CGRP in motor endplates. In addition, its role in the release of ACh has been questioned (2).
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To clardy these apparent controversies, we aimed to prow whether or not CGRP is a regular component of motor endplates in three different vertebrate species. A broader objective of our studies was to determine whether the excitation-induced release of CGRP, as suggested by radiochemical investigations (25), could also be supported by immunohistochemical studies, and whether CGRP is present in cholinergic synapses in general. Parts of our results have been published in abstract form (6-8).
Materials and Methods
Investigations were performed on young adult albino rats (Rattus a Z h s norvegicus) of both sexes [R-Amsterdam (CFY) strain; body weight 220-250 g]. Additional studies were performed on three adult monkeys (Macacafarcicuhta, body weight 6-8 kg) and on Hungarian frogs (Rana esculenta), body weight 100 g. Under sodium pentobarbital anesthesia (IP 50 mg/kg body weight), the animals were subjected to transcardial perfusion-fixation with Zamboni's picric acid-formaldehyde mixture, preceded by a flush with isotonic saline solution. CGRP was visualized in free-floating frozen sections for light microscopy (LM) and in Vibratome sections for electron microscopy (EM). Immunohistochemistry was performed according to Sternberger's pre-embedding PAP method, using standard Amersham (Poole, UK) antisera as described earlier (23). For EM, Vibratome sections were dissected under a stereo microscope, post-fixed in Millonig's buffered osmic acid, dehydrated in graded alcohols, processed in propylene oxide, and embedded in Durcupan ACM. Thin sections (silver interference color) were obtained on a Reichert Ultracut, using a diamond knife. Sections were stained with lead citrate and photographed on a Tesla SOOB electron microscope.
Surgery. Transection (n = 8) or crush (n = 10) of the sciatic nerve was performed in the upper thigh, close to the sciatic notch. Bupivacaine (Marcaine; Astra, Sodertalje, Sweden) was injected in daily doses of 1 ml(7 mg) into the tissue space between the masseter and the buccinator muscle (n = 5). Crush of the phrenic nerve (rz = 5) was performed in the cervical region where the nerve proceeds alongside the anterior scalenus muscle.
Supramaximal stimulation of the sciatic nerve was performed with Wsec square pulses, 5 msec duration, for 10-30 min. with silver wire electrodes at 1.2 V.
Results
In the flexor digitorum brevis muscle in the rat, CGRP-immunoreactive motor nerve terminals displayed the classical features of motor endplates. Similar pictures could be obtained in the lumbrical and interosseus muscles. At the EM level, CGRP immunoreactivity outlined synaptic vesicles and mitochondria that stood out as non-reactive units from the immunoreactive terminal axoplasm (Figure 1 ). However, after supramaximal stimulation of the sciatic nerve (1.2 V, 5 0 Hz, 0.4 msec square pulses) the majority of CGRPreactive motor endplates were transformed into depleted "ghosts." The percentage of ghosts vs normally reacting motor endplates was proportional to the time of duration of the supramaximal stimulation (Table 1) . Under the electron microscope, ghosts were characterized by a decreased number of synaptic vesicles and were devoid of the CGRP-active ''shell'' seen in normal endplates (Figure 2) .
Although several other muscles also contained CGRP-positive endplates (Figure 3 ), in an overwhelming majority of rat striated muscles NMJs did not display any CGRP-like immunoreactivity (Table 2). However, chronic immobilization of such muscles with the local anesthetic bupivacaine administered in daily doses of 1 ml (= 7 mg) locally for 4-12 days resulted in elicitation of CGRP immunoreactivity in the motor endplates (Figure 4) . Such NMJs were slightly different from those present in normally reacting muscles owing to peculiar local enlargements and spike-like outgrowths also visible with silver impregnation techniques.
Transection ofthe sciatic nerve at mid-thigh level resulted, within 48 h, in total depletion of CGRP from the flexor digitorum brevis muscle. In addition, NMJs in the interosseus pedis and those in the lumbrical pedis muscles were completely depleted. Crush injury of the sciatic nerve at mid-thigh level also resulted, within 48 hr, in depletion of CGRP-like immunoreactivity from motor endplates of the flexor digitorum brevis, lumbrical, and plantar interosseus muscles, in a manner similar to that seen after nerve transection.
In contrast, 3-4 weeks after crush injury of the sciatic nerve, NMJs in the flexor digitorum, lumbrical, and interosseus pedis muscles regain again their CGRP immunoreactivity. Partially reestablished motor endplates displayed strong CGRP immunoreactivity, whereas others yielded a very faint reaction. These variations suggest that structural and functional regeneration of motor endplates had not been completed.
At the same time, i.e., 3-5 weeks after crush injury of the sciatic nerve, representing the first month of regeneration, formerly inert NMJs, such as those in the gastrocnemius, started to exhibit very strong CGRP immunoreactivity. During this period of regenerative maturation, immunoreactivity ofthe motor endplates in otherwise non-reacting muscles could not be distinguished from the few muscles that, under normal conditions, exhibit CGRP immunoreactivity (Figure 5 ). Three months after the initial crush injury, CGRP immunoreactivity of endplates in the gastrocnemius muscle disappeared again. Essentially analogous is the situation in the rat diaphragm, notorious for failing to exhibit CGRP immunoreactivity under normal conditions. During axon regeneration after initial degeneration, 16 days after unilateral crush injury to the phrenic nerve at the cervical region NMJs in the ipsilateral hemidiaphragm exhibited conspicuously strong CGRP immunoreactivity ( Figure 6) .
In striated muscles of primates, CGRP immunoreactivity of the motor endplates displayed the characteristic features of very elaborate neuromuscular junctions. Such strongly immunoreactive NMJs included those in the diaphragm (Figure 7) .
Finally, in amphibian muscles, all the motor endplates studied exhibited CGRP immunoreactivity. In tetanic muscles, such as the thoracohumeral and the tetanic portion of the iliofibular, Kiihne's bush-like endings, consisting of parallel pallisades of the terminal, displayed strong immunoreactivity (Figures 8a and 8b) . On the other hand, grape-like endings of the "small nerve system" innervating tonic muscles such as the "Tonusbiindel" of the iliofibular d i b i t e d less intense CGRP immunoreactivity (Figure 8c ). 
Discussion
Recent studies from Kreutzberg's laboratory have shown that CGRP is accumulated in the perikarya of motorneurons after axotomy (14,34), a peculiar finding that focused interest on CGRP in cholinergic terminals. New and Mudge (27) proved that synthesis of AChR in striated muscles is regulated by CGRP; similar results were obtained by Jennings and Mudge (16) in tissue cultures. Simultaneously, Fontaine et al. (12) have shown that CGRP coexisting with ACh in the NMJ plays a trophic role insofar as it induces increased activity of genes that encode expression of a-subunits of the AChR by activating the enzyme adenyl cyclase. According to I (32) . and Ohhashi and Jacobawitz (28). prove not only that CGRP coexists with ACh in the motor endplate but that it is also relcased from the axon terminal as a consequence of electrical or chemical stimulation. Therefore. CGRP virtually becomes one of the indispensable participants in cholinergic transmission mechanism.
M. bulbocavernosus
According to Changeux (3), CGRP elevates intracellular levels of cyclic AMP and activates adenylate cyclase. In this way it regulates biosynthesis of the AChR by an intracellular pathway different from electrical activity. Consequently, CGRP is an "anterograde trophic factor" responsible for the compartmentalized expression of the AChR.
Our present studies indicate that CGRP is a regular constituent of amphibian and mammalian neuromuscular junctions. Motor endplates also display a strong CGRP reaction in several skeletal and visceral muscles. Furthermore, it has been shown that CGRP is successively depleted from the terminal axoplasm of the neuromuscular junction on supramaximal electrical stimulation of the motor nerve. At the same time, in many mammalian skeletal muscles NMJs do not normally exhibit CGRP immunoreactivity. In such muscles as the buccinator of the rat, chronic inactivation of neuromuscular transmission elicits CGRP in the motor endplates. Bupivacaine is known to immobilize skeletal muscles by blocking action potentials in nerve and muscle as well as the action of ACh at the NMJ (30.33). Accordingly, paralysis of the muscle after bupivacaine treatment is due not to necrosis or damage to the nerve terminals (18,19) but rather to blockade of transmitter release from the motor nerve terminals. Thus, the "piling up" of CGRP in the inactivated (but not degenerated) axon terminals is a simple consequence of lack of synaptic function, i.e., lack of exocytosis of the transmitter ACh and the coexisting CGRP. This is quite the opposite of the effect of supramaximal stimulation, which results in depleted "ghosts," i.e., in depletion of CGRP as well as ACh. In terms of teleology it can be hypothesized that in bupivacaine paralysis, there is "no need" for CGRP to be released because the AChR is not "worn out" in the absence of ACh release. In this context it should be recalled that the peculiar "spiny" appearance of bupivacaine-reactivated CGRP-reactive NMJs might be due to the absence of local CGRP regulatory action, which has been shown to prevent ultraterminal branching (36).
Although disappearance of CGRP-like immunoreactivity from degenerating motor endplates after transection of the motor nerve is an inevitable consequence of Wallerian degeneration, it is more difficult to explain the surprising elicitation of CGRP immunoreactivity in regenerating motor endplates of normally non-reacting muscles, e.g., gastrocnemius. and especially in the diaphragm. Since this strong and conspicuous immunostaining disappears in the course of a few weeks after axon regeneration, it can be assumed that during the early phase of regeneration structurally reestablished motor endplates are not functionally active. In other words, the situation is similar, or at least analogous, to that seen after muscle paralysis. On the other hand, the possibility cannot be excluded that this simply represents the manifestation of tremendously increased CGRP expression of the motor neuron, elicited by the damage to the peripheral axon. It has been shown (10) that transection of the facial nerve results in marked increase of CGRP reactivity Figure 6 . CGRP immunoreactivity in the rat diaphragm (a) under normal conditions and (b,c) 16 days after crushing the ipsilateral phrenic nerve. Note that normally only the motor axons display CGRP reaction, whereas no motor endplates were stained. m, mast cell. In contrast, shortly after regeneration neuromuscular junctions are filled with CGRP, resulting in complete immunostaining of the endplates. Bar = 10 pm. -of facial motor neurons. In an analogous manner, it can be assumed that crushing the sciatic nerve induces similar changes in the ipsilateral lumbosacral motor neuron pool which has already been observed in the course of earlier experiments (6,8) . Accordingly, the greater amount of CGRP expressed by the motor neuron will manifest itself via axoplasmic flow in regenerating endplates. After complete normalization of the motor unit, not only does perikaryal CGRP decrease in the related perikarya but this decrease followed by the disappearance of CGRP from the motor endplates of the gastrocnemius and other similar non-reacting muscles. Therefore, it appears that CGRP coexists with ACh in neuromuscular synapses and, like a biological "tracer bullet," it is released on stimulation. One of the striking, and admittedly controversial, questions is whether under normal conditions and after experimental enhancement alike (either by axonal regeneration or by bupivacaine treatment) CGRP is present not in synaptic vesicles but rather in the terminal axoplasm surrounding them. Without going into lengthy arguments, it should be mentioned that even ACh is far from being definitely located within the synaptic vesicles; in one of our early experiments ( 5 ) we suggested that the transmitter molecules of ACh are attached to the external surface of the vesicles, which might also be true for CGRP. Another possibility is that large dense-core vesicles, which normally contain CGRP. are ruptured or rather burst, releasing CGRP into the free axoplasm. Finally, the possibility cannot be excluded that both ACh and other mediator-related substances, including CGRP, are normally freely dissolved in the terminal axoplasm, as proposed two decades ago by Whittaker (38). This question should be addressed in more detail elsewhere. With regard to the role ofCGRP, it is assumed (27) that CGRP regulates the number and function of AChR molecules in motor endplates. In this context, the bupivacaine experiments, and especially elicitation of CGRP in the course of axon regeneration in normally non-reacting muscles such as the diaphragm (a major argument repeatedly used against the idea of CGRP participation in the regulation of the a-subunit of the AChR), seem to be important in supporting the CGRP AChR theory (3,4,12,13,27 ). Further studies are needed to determine whether or not other nicotinic synapses, notably those of initial axon collaterals impinging on Renshaw elements (9,l l), display similar functional features.
